Recon Top Stories AlloSource Announces 200th Implant Of AceConnex® Pre-Sutured Fascia Device For Hip Labral Reconstruction And Augmentation byJosh SandbergMarch 27, 2025
Biologics AlloSource Medical Director Dr. Hannis Thompson Recognized For His Exceptional Contributions In Tissue Banking At AATB Annual Meeting byTim AllenOctober 3, 2024
Recon AlloSource® Launches AceConnex® First Pre-Sutured Fascia Device for Hip Labral Reconstruction and Augmentation byJosh SandbergJune 12, 2024
Recon Sports Medicine Top Stories AlloSource Announces First Implant of AceConnex™ Pre-Sutured Fascia Device in Hip Labral Reconstruction Procedure byJosh SandbergNovember 8, 2023
Regulatory Sports Medicine AlloSource Receives FDA 510(k) Clearance For AceConnex™ Pre-Sutured Fascia For Hip Labral Reconstruction And Augmentation byJosh SandbergJuly 11, 2023
Biologics Study on Prochondrix Osteochondral Allograft Published in the Journal of Orthopaedic Surgery Demonstrates Encouraging Outcomes when Used on Isolated Articular Cartilage Defects byJosh SandbergJune 29, 2023
Biologics Top Stories AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction byJosh SandbergMay 25, 2023
Biologics Top Stories AlloSource Announces Dean Elliott As New President And CEO byChris StewartOctober 19, 2022
Biologics AlloSource®Adds Quadricep Tendons To Its AlloConnex™ Line Of Tendons, Ligaments And Fascia byChris StewartJuly 12, 2022
Biologics Extremities Spine Top Stories ALLOSOURCE®Announces New Micro Fibers Demineralized Bone Allograft byChris StewartJune 28, 2022
